Sponsor Pipeline

Qurient Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05394103 Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors Advanced Cancer Recruiting
NCT05438420 Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With… Esophageal Cancer Active, Not Recruiting
Phase 1
NCT07138196 A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host… Chronic Graft-Versus-Host Disease Recruiting
Disease Areas
Gastric Cancer (1) Cervical Cancer (1) Esophageal Cancer (1)
Get alerts when Qurient Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free